The Comparison of Intraventricular Injection of Mu Receptor Agonist (Morphine) and Antagonist (Naloxone) on the Occurrence of Fear Behavior in Adult Male Rats
Archives of Advances in Biosciences,
Vol. 15 No. 1 (2024),
24 January 2024
,
Page 1-12
https://doi.org/10.22037/aab.v15i1.43531
Abstract
Introduction: Drugs are among the opioid-like compounds that lead to the development of emotional behaviors in humans and animals. One of the emotional behaviors is stress behavior caused by fear, which can be caused by opioid and quasi-opioid compounds.
In this study, the effect of intraventricular injection of brain (I.C.V) agonist (morphine sulfate) and hair receptor antagonist (naloxone) on fear behavior in adult male Wistar rats was investigated.
Materials and Methods: In this study, pure harmalin was used as a hallucinogenic drug that causes hallucinations and fear in animals as a positive control and saline as a sham was used for comparative studies with groups treated with morphine sulfate and naloxone. In this study, stereotax machine was used for cannulation and injection of I.C.V and Elevated plus-maze machine was used for behavioral testing.
Results: The values used to treat the experimental groups for morphine sulfate (0.5, 1, 2.5, 5, 7μg/rat) and naloxone (0.5, 1, 2μg/rat) were selected. The results of intraventricular injection of (1, 2.5, 5μg/rat) morphine in the brains of rats in the experimental group showed a significant difference in the occurrence of fear behavior compared to the positive control group with P <0.05.
While injection of values (0.5, 7μg/rat) did not show a significant difference with p <0.05 compared to the positive control group. Also, the results of intraventricular injection (I.C.V) of naloxone (1μg/rat) showed a significant difference with p <0.05 in the occurrence of fear behavior in comparison with the positive control group. While injection of values (0.5, 2.5μg/rat) did not show a significant difference with P <0.05 compared to the positive control group. In this study, I.C.V (50 µg / rat) injection of pure harmalin, which is considered as a positive control group, shows the percentage of entry into the open arm and also the percentage of retention time in the open arm.
Conclusion: In conclusion, none of the data used in the present study in the area has a uniform performance and this diversity can be considered as a result of various mechanisms that require more detailed studies.
- Elevated plus-maze
- Fear
- Naloxone
- Rat
- Sulfate morphine
How to Cite
References
Botelho AP, Gameiro GH, Tuma CEdSN, Marcondes FK, Ferraz de Arruda Veiga MC. The effects of acute restraint stress on nociceptive responses evoked by the injection of formalin into the temporomandibular joint of female rats. Stress. 2010;13(3):269-75. [DOI: 10.3109/10253890903362645] [PMID]
Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M, et al. Differential effects of μ-, δ-and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur J Pharmacol. 1997;324(1):21-9. [DOI: 10.1016/s0014-2999(97)00062-9] [PMID]
Cheney D, Robinson S, Malthe-Sørenssen D, Wood P, Commissiong J, Costa E, editors. Regulation of the Cholinergic Septal-hippocampal Pathway: Role of Dopaminergic Septal Afferents. Neuropsychopharmacology: Proceedings of the 7th International Congress of Pharmacology, Paris, 1978. 2013;5:241.
Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug and Alcohol Dependence-Shannon. 1998;51(1):23-48.
Tanaka M, Kohno Y, Nakagawa R, Ida Y, Iimori K, Hoaki Y, et al. Naloxene enhances stress-induced increases in noradrenaline turnover in specific brain regions in rats. Life Sci. 1982;30(19):1663-9. [DOI: 10.1016/0024-3205(82)90499-4] [PMID]
Yamada K, Nabeshima T. Stress-induced behavioral responses and multiple opioid systems in the brain. Behav Brain Res. 1995;67(2):133-45. [DOI: 10.1016/0166-4328(94)00150-e] [PMID]
Schaefer GJ, Holtzman SG. Morphine-like stimulus effects in the monkey: Opioids with antagonist properties. Pharmacol Biochem Behav. 1981;14(2):241-5. [DOI: 10.1016/0091-3057(81)90250-1] [PMID]
Caldarone BJ, Abrahamsen GC, Stock HS, Mongeluzi DL, Rossellini RA. Enhancement op morphine analgesia in rats following removal from contextual conditioned fear cues. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21(6):981-95. [DOI: 10.1016/s0278-5846(97)00093-6] [PMID]
Novak BH, Hudlicky T, Reed JW, Mulzer J, Trauner D. Morphine synthesis and biosynthesis-an update. Current Organic Chemistry. 2000;4(3):343-62. [DOI: 10.2174/1385272003376292]
Basilisco G, Camboni G, Bozzani A, Paravicini M, Bianchi P. Oral naloxone antagonizes loperamide-induced delay of orocecal transit. Dig Dis Sci. 1987;32(8):829-32. [DOI: 10.1007/BF01296704] [PMID]
Bodnar RJ, Lamonte N, Israel Y, Kandov Y, Ackerman TF, Khaimova E. Reciprocal opioid–opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating μ agonist-induced feeding in rats. Peptides. 2005;26(4):621-9. [DOI: 10.1016/j.peptides.2004.11.007] [PMID]
Assaf S, SY A, JJ M. Excitatory action of the mesolimbic dopamine system on septal neurones. Brain research. 1977;129(2):353-60. [DOI: 10.1016/0006-8993(77)90015-4]
Rougé‐Pont F, Mayo W, Marinelli M, Gingras M, Le Moal M, Piazza PV. The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens. Eur J Neurosci. 2002;16(1):169-73. [DOI: 10.1046/j.1460-9568.2002.02084.x] [PMID]
Orlowski J. Heterologous expression and functional properties of amiloride high affinity (NHE-1) and low affinity (NHE-3) isoforms of the rat Na/H exchanger. J Biol Chem. 1993;268(22):16369-77. [PMID]
Proescholdt M, Hutto B, Brady L, Herkenham M. Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C] inulin in rat. Neuroscience. 1999;95(2):577-92. [DOI: 10.1016/s0306-4522(99)00417-0] [PMID]
Park CG, Leenen F. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. J Korean Med Sci. 2001;16(5):553-7. [DOI: 10.3346/jkms.2001.16.5.553] [PMID] [PMCID]
Komada M, Takao K, Miyakawa T. Elevated plus maze for mice. J Vis Exp. 2008;(22):1088. [DOI: 10.3791/1088] [PMID] [PMCID]
Yokoo H, Tanaka M, Yoshida M, Tsuda A, Tanaka T, Mizoguchi K. Direct evidence of conditioned fear-elicited enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis. Brain research. 1990;536(1-2):305-8. [DOI: 10.1016/0006-8993(90)90039-E]
Gallagher M, Kapp B. Manipulation of opiate activity in the amygdala alters memory processes. Life sciences. 1978;23(19):1973-7. [DOI: 10.1016/0024-3205(78)90565-9] [PMID]
Smart D, Lambert DG. Tyr-d-Arg2-Phe-sarcosine4 activates phospholipase C-coupled μ2-opioid receptors in SH-SY5Y cells. Eur J Pharmacol. 1996;305(1-3):235-8. [DOI: 10.1016/0014-2999(96)00239-7] [PMID]
Wong M-L, Licinio J, Pasternak KI, Gold PW. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain
by in situ hybridization histochemistry. Endocrinology. 1994;135(5):2275-8. [DOI: 10.1210/endo.135.5.7956950] [PMID]
Henry DJ, Hu X-T, White FJ. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology (Berl). 1998;140(2):233-42. [DOI: 10.1007/s002130050762] [PMID]
Goosens KA, Maren S. Pretraining NMDA receptor blockade in the basolateral complex, but not the central nucleus, of the amygdala prevents savings of the conditional fear. Behav Neurosci. 2003;117(4):738-50. [DOI: 10.1037/0735-7044.117.4.738] [PMID]
Morris MD, Gebhart G. The effect of morphine on fear extinction in rats. Psychopharmacology. 1978;57(3):267-71. [DOI: 10.1007/BF00426749] [PMID]
Anseloni VC, Coimbra NC, Morato S, Brandão ML. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test. Exp Brain Res. 1999;129(2):260-8. [DOI: 10.1007/s002210050896] [PMID]
Colasanti A, Rabiner E, Lingford-Hughes A, Nutt D. Opioids and anxiety. J Psychopharmacol. 2011 Nov;25(11):1415-33. [DOI: 10.1177/0269881110367726] [PMID]
Zarrindast M-R, Habibi M, Borzabadi S, Fazli-Tabaei S, Yahyavi SH, Rostamin P. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol. 2002;451(3):287-93. [DOI: 10.1016/s0014-2999(02)02149-0] [PMID]
Nichols DE, Nichols CD. Serotonin receptors. Chem Rev. 2008;108(5):1614-41. [DOI: 10.1021/cr078224o] [PMID]
Zinebi F, McKernan M, Shinnick-Gallagher P. Expression of fear-conditioning is accompanied by increased paired-pulse depression within the amygdala. Pharmacol Biochem Behav. 2002;71(3):393-400. [DOI: 10.1016/s0091-3057(01)00684-0] [PMID]
- Abstract Viewed: 63 times
- pdf Downloaded: 63 times